Zurich Cantonal Bank’s Centessa Pharmaceuticals CNTA Stock Holding History

Zurich Cantonal Bank’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-438	Closed	-$11K	–	2782
2025 Q4	$11K	Buy	+438	New	+$11.1K	﹤0.01%	2481

Zurich Cantonal Bank's CNTA Position: Q2 2026 in Review

Zurich Cantonal Bank sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 1 share — an estimated $40 sold.

Zurich Cantonal Bank first reported a position in CNTA in Q1 2024 and held it in 8 quarters. The position peaked at $35.2K in Q3 2024. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Zurich Cantonal Bank reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Zurich Cantonal Bank sold 1 Centessa Pharmaceuticals share in Q2 2026, an estimated $40.
Zurich Cantonal Bank first reported a position in Centessa Pharmaceuticals in Q1 2024 and held it in 8 quarters.
Zurich Cantonal Bank's Centessa Pharmaceuticals position peaked at $35.2K in Q3 2024.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.